Scientists begin first-ever human trial of AI-created vaccine

A vaccine antigen created by AI has now successful moved on to the human testing stage following a small Phase 1 trial. The University of Cambridge, alongside biotech company DIOSynVax, confirmed that the AI COVID-19 vaccine antigen proved safe when administered to people earlier in the month. They say that developing medicine in this way […]